|
Match
|
Document |
Document Title |
|
|
7387789 |
Transdermal delivery of non-steroidal anti-inflammatory drugs
The present invention provides a transdermal drug delivery system which comprises: a therapeutically effective amount of a non-steroidal anti-inflammatory drug; at least one dermal penetration...
|
|
|
7378097 |
Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant
A transcutaneous immunization system where the topical application of an adjuvant and an antigen or nucleic acid encoding for an antigen, to intact skin induces a systemic or mucosol antibody...
|
|
|
7241731 |
Oligopeptides for promoting hair growth
The present invention provides oligopeptides having morphogenesis promoting activity and in particular, hair promoting activity. The oligopeptides may be in monomer form, monomer having a reactive...
|
|
|
EP1769785A1 |
Dermal penetration enhancers and drug delivery systems involving same
A transdermal drug delivery system which comprises at least one physiologically active agent or prodrug thereof and at least one dermal penetration enhancer, characterised in that the dermal...
|
|
|
7094422 |
Topical delivery of antifungal agents
The present invention provides a topical drug delivery system which comprises: a therapeutically effective amount of an antifungal agent; at least one dermal penetration enhancer, which is a safe...
|
|
|
7037499 |
Adjuvant for transcutaneous immunization
A transcutaneous immunization system delivers antigen to immune cells without perforation of the skin, and induces an immune response in an animal or human. The system uses an adjuvant, preferably...
|
|
|
6998138 |
Topical delivery of anti-alopecia agents
The present invention provides a topical drug delivery system which comprises: a therapeutically effective amount of an anti-alopecia agent; at least one dermal penetration enhancer, which is a...
|
|
|
6964777 |
Transdermal delivery of antianxiety agents
The present invention provides a transdermal drug delivery system which comprises: a therapeutically effective amount of an antianxiety agent; at least one dermal penetration enhancer, which is a...
|
|
|
6958154 |
Spray on bandage and drug delivery system
The present invention provides novel “patch in a bottle” technology in which a fluid composition, e.g., an aerosol spray, is applied onto a surface as a fluid, but then dries to form a covering...
|
|
|
6929801 |
Transdermal delivery of antiparkinson agents
The present invention provides a transdermal drug delivery system which comprises: a therapeutically effective amount of an antiParkinson agent; at least one dermal penetration enhancer, which is a...
|
|
|
6923983 |
Transdermal delivery of hormones
The present invention provides a transdermal drug delivery system which comprises: a therapeutically effective amount of a hormone; at least one dermal penetration enhancer, which is a safe...
|
|
|
6916487 |
Transdermal delivery of antiemetics
The present invention provides a transdermal drug delivery system which comprises: a therapeutically effective amount of an antiemetic; at least one dermal penetration enhancer, which is a safe...
|
|
|
6916486 |
Transdermal delivery of analgesics
The present invention provides a transdermal drug delivery system which comprises: a therapeutically effective amount of an analgesic; at least one dermal penetration enhancer, which is a safe...
|
|
|
EP0746294B1 |
ABSORPTION ENHANCERS FOR TOPICAL PHARMACEUTICAL FORMULATIONS
Abstract not available
|
|
|
6825234 |
Compositions and methods for amelioration of human female sexual dysfunction
The invention provides compositions and methods suitable for ameliorating female sexual dysfunction, and in particular, female sexual arousal disorder. In one embodiment, the invention provides a...
|
|
|
6818226 |
Dermal penetration enhancers and drug delivery systems involving same
A transdermal drug delivery system which comprises at least one physiologically active agent or prodrug thereof and at least one dermal penetration enhancer; characterised in that the dermal...
|
|
|
6797276 |
Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
A transcutaneous immunization system where the topical application of an adjuvant and an antigen or nucleic acid encoding for an antigen, to intact skin induces a ystemic or mucosol antibody...
|
|
|
6627216 |
Spray on bandage and drug delivery system
The present invention provides novel “patch in a bottle” technology in which a fluid composition, e.g., an aerosol spray, is applied onto a surface as a fluid, but then dries to form a covering...
|
|
|
6486207 |
Compositions and methods for amelioration of human female sexual dysfunction
The invention provides a composition suitable for topical application comprising: an effective amount of a prostaglandin, a polymer thickener, a lipophilic component, and a buffer system. In...
|
|
|
6414028 |
Topical compositions containing prostaglandin E1
A topical composition of a semi-solid consistency suitable is provided for transdermal application of prostaglandin E 1 . The composition comprises prostaglandin E 1 , a penetration enhancer, a...
|
|
|
6299900 |
Dermal penetration enhancers and drug delivery systems involving same
A transdermal drug delivery system which comprises at least one physiologically active agent or prodrug thereof and at least one dermal penetration enhancer; characterized in that the dermal...
|
|
|
6288151 |
Alkylated aminoalkyl cyclic urea surfactants
Novel alkyl aminoalkyl cyclic urea compounds of the structural formula: ##STR1## wherein each of m, n, and o are independently 1 or 2, p is 0 or 1, R 1 is C 1 to C 4 linear or branched alkyl,...
|
|
|
6118020 |
Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate
Dodecyl 2-(N,N dimethylamino)-propionate (DDAIP) is prepared by transesterification of ethyl 2-(N,N-dimethylamino) propionate. Crystalline acid addition salts of DDAIP are prepared by cooled mixing...
|
|
|
EP1028708A1 |
TOPICAL COMPOSITIONS FOR PROSTAGLANDIN E 1? DELIVERY
Abstract not available for EP1028708 Abstract of corresponding document: US6046244 A topical composition of a semi-solid consistency suitable is provided for transdermal application of...
|
|
|
6083996 |
Topical compositions for NSAI drug delivery
An aqueous pharmaceutical composition of a semi-solid consistency is provided for topical application of non-steroidal anti-inflammatory (NSAI) drugs. The composition comprises one or more NSAI...
|
|
|
6046244 |
Topical compositions for prostaglandin E.sub.1 delivery
A topical composition of a semi-solid consistency suitable is provided for transdermal application of prostaglandin E 1 . The composition comprises prostaglandin E 1 , a penetration enhancer, a...
|
|
|
5916587 |
Transdermal delivery matrix for piroxicam
The present invention is directed to a pharmaceutical compositions improving percutaneous absorbability by absorption assistants, which remarkably increase permeation and dissolution of piroxicam,...
|
|
|
RE36138 |
Percutaneous absorption promoter, a tape plaster and a method of promoting percutaneous absorption
A percutaneous absorption promoter comprises a derivative of amino acid in which the amino group has or does not have an acyl substituent or a hydrocarbon substituent, the carboxylic group has a...
|
|
|
5679829 |
Arginine derivatives, process of preparation, uses, and compositions comprising them
New arginine derivatives containing an N α -alkyloxycarbonyl group of formula (I) ##STR1## in which R represents a linear or branched alkyl radical having from 8 to 22 carbon atoms, salts thereof,...
|
|
|
5413794 |
Percutaneous absorption promoter, a tape plaster and a method of promoting percutaneous absorpton
A percutaneous absorption promoter comprises a derivative of amino acid in which the amino group has or does not have an acyl substituent or a hydrocarbon substituent, the carboxylic group has a...
|